Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID06851936

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Led by University of Florida · Updated on 2026-05-15

204

Participants Needed

1

Research Sites

7 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a tobacco cessation program tailored for cancer survivors and their family members or caregivers who use tobacco. The study also involves training healthcare providers in a specific model to better help patients quit tobacco. This program aims to address the unique challenges faced by people trying to quit tobacco after a cancer diagnosis by providing support that includes caregivers as well as survivors themselves. Participants will complete a nicotine cessation program consisting of four sessions lasting about 60 minutes each. These sessions will be delivered by a Tobacco Treatment Specialist through videoconference or telephone. Cancer survivors and their caregivers may participate together. Those who qualify may also receive free nicotine replacement therapy during the study. Additionally, healthcare providers will be trained using the AAC model and communication skills to support tobacco cessation in cancer care. During the study, participants will undergo assessments to measure program reach, effectiveness in helping people quit tobacco, satisfaction, adherence, and perspectives on the program's feasibility and acceptability. Healthcare providers’ adoption and perspectives on the intervention will also be evaluated. The study includes baseline assessment and follow-up periods up to 18 months. Participants can expect regular contact and support throughout the program, with evaluations occurring during and after treatment completion.

CONDITIONS

Brief Title

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years and older
  • Current user of any tobacco or nicotine product in the past month
  • Cancer survivors or patients currently receiving cancer-related treatments
  • Receiving care from participating UF Health clinics (Medical Oncology, Urology, Radiation Oncology)
  • Capable of completing study requirements
  • Able to provide informed consent and agree to comply with study processes
  • Family members, informal caregivers, or friends of enrolled cancer survivors receiving care from the participating clinics
  • Capable of completing study requirements
  • Able to provide informed consent and agree to comply with study processes
Not Eligible

You will not qualify if you...

  • Unable to complete study sessions due to language, travel, or technology barriers
  • Prisoners, involuntarily incarcerated individuals, or those compulsorily detained for psychiatric or physical illness treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Outpatient Treatment

Duration - Approximately 4 weeks

Participants complete a nicotine cessation program consisting of 4 sessions delivered by a Tobacco Treatment Specialist via videoconference or telephone. Dyad enrollees complete sessions together. Participants may receive free nicotine replacement therapy if medically appropriate.

4 sessions (remote)

Follow-up

Duration - Up to 5 months after baseline assessment

Participants are assessed for tobacco cessation effectiveness, satisfaction, adherence, and perspectives on program feasibility and acceptability after completing the cessation program or at specified timepoints if sessions are not completed.

1 to 3 follow-up assessments (remote or in-person) depending on completion status

Trial Site Locations

Total: 1 location

1

University of Florida

Gainesville, Florida, United States, 32608

Actively Recruiting

Loading map...

Research Team

E

Erika Barahona, M. Ed

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here